It has been studied that the expression of BTK is correlated with clinic characteristics (tumor staging and metastasis) negatively and related to the survival of LUAD patients positively, and BTK may be responsible for maintaining the immunodominant state of the tumor microenvironment [23]. This evidence concerns the gene BTK and neoplasm.